Northern Star – Buy

Posted on | by Leon Hinde

Northern Star Resources is under Algo Engine buy conditions and is our preferred gold exposure.

NST continues to deliver strong results in the June quarter. Group production finished with 450koz at $1460oz, (up 23%), whilst seeing costs come down almost 10%.

We continue to see the twin factors of a strong gold price and cost-saving, (post-merger with SAR), helping to support the share price.

Buy NST

Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.

Model Portfolio Email Alerts

Posted on | by Craig

We’ve changed how our Model Portfolio emails are sent out to subscribers. From now on, all model changes will be included in our daily blog post at 11am, while your custom selections, will be emailed to you at 8am.

To customize the models you’re interested in tracking, use the toggle option in the toolbar of the Model Portfolio window in our Members Area. Select the model you’re interested in, (or no longer interested in) and press the grey or green envelope.

Grey means that we will not email you about changes to that model. Green means that we will. Remember, this setting is unique to each Model and our alerts are sent out each morning at around 8 am.

Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.